This study characterizes several novel activities of SARS-CoV-2 helicase nsp13, providing valuable insights into potentially new functions of this essential RNA-processing enzyme in the virus life ...
Yes, high-level summits are on hiatus. But the group continues to function in ways that are less visible, more functional, ...
MedPage Today on MSN
Cell Therapy Slows Upper Limb Decline in Duchenne Muscular Dystrophy
Investigational deramiocel is back under FDA review again ...
Results consistent with pre-clinical studies demonstrating that, in the early stages of the neurodegenerative process, ...
Presentation reinforces ATH434's clinical profile ahead of Phase 3 engagement with regulators - MELBOURNE, Australia and SAN FRANCISCO, April 22, 2026 (GLOBE NEWSWIRE)-- Alterity Therapeutics (ASX: ...
A new Pearl Meyer survey reveals that the AI bottleneck isn’t about technology. It’s a warning that some senior executive ...
Walking speed isn’t just about fitness—it’s a powerful indicator of overall health, longevity, and independence. Learn what ...
The treatment landscape of generalised myasthenia gravis, a prototypic antibody-mediated disorder of the neuromuscular junction, has considerably evolved in the past 8 years.1 The approval of targeted ...
3d
Liver hormone regulates appetite and metabolism by targeting a specific group of hindbrain neurons
Researchers at Pennington Biomedical Research Center provide critical insight into how the brain and body work together to ...
Key opinion leaders (KOLs) previously interviewed by GlobalData have noted that there is a significant unmet need for effective treatments for patients who are Musk+, LRP4+, or triple seronegative.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results